Development of bozepinib-loaded nanocapsules for nose-to-brain delivery: preclinical evaluation in glioblastoma

被引：7
|
作者：
Dias, Amanda de Fraga [1 ]
Dallemole, Danieli Rosane [2 ]
Bruinsmann, Franciele Aline [2 ]
Lopes Silva, Luiz Fernando [1 ]
Cruz-Lopez, Olga [3 ,4 ]
Conejo-Garcia, Ana [3 ,4 ]
Oliveira Battastini, Ana Maria [1 ]
Maria Campos, Joaquin [3 ,4 ]
Guterres, Silvia Staniscuaski [2 ]
Pohlmann, Adriana Raffin [2 ]
Figueiro, Fabricio [1 ,5 ]
机构：
[1] Univ Fed Rio Grande do Sul, Inst Ciencias Basicas Saude, Programa Posgrad Ciencias Biol Bioquim, Porto Alegre, RS, Brazil
[2] Univ Fed Rio Grande do Sul, Fac Farm, Programa Posgrad Ciencias Farmaceut, Porto Alegre, RS, Brazil
[3] Fac Farm, Dept Quim Farmaceut & Organ, C Campus Cartuja S-N, Granada, Spain
[4] Inst Invest Biosanitaria Granada Ibs GRANADA, Granada, Spain
[5] Univ Fed Rio Grande do Sul, Inst Ciencias Basicas Saude, Dept Bioquim, Porto Alegre, RS, Brazil
来源：
NANOMEDICINE | 2021年 / 16卷 / 23期
关键词：
bozepinib; drug delivery; glioblastoma; intranasal; lipid-core nanocapsules; temozolomide; LIPID-CORE NANOCAPSULES; DRUG-DELIVERY; POLYMERIC NANOPARTICLES; INTRANASAL DELIVERY; EXPERIMENTAL-DESIGN; GROWTH-INHIBITION; IN-VITRO; CHITOSAN; COMBINATION; GLIOMA;
D O I：
10.2217/nnm-2021-0164
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Aim: To develop and characterize bozepinib-loaded lipid-core nanocapsules (BZP-LNC+) as a potential treatment for glioblastoma (GBM). Methods: Characterization of nanocapsules was performed by diameter, polydispersity index, zeta potential, pH and encapsulation efficiency. GBM cell viability, cell cycle and Annexin/PI were evaluated after BZP-LNC+ treatment. Synergism between BZP-LNC+ and temozolomide (TMZ) was performed by CompuSyn software and confirmed in vitro and in vivo. Results: BZP-LNC+ showed adequate particle sizes, positive zeta potential, narrow size distribution and high encapsulation efficiency. BZP-LNC+ reduces GBM growth by inducing apoptosis. BZP-LNC+ and TMZ showed synergistic effect in vitro and reduced the in vivo glioma growth by approximately 81%. Conclusion: The present study provides proof-of-principle insights for the combination of these drugs for GBM treatment.
引用
收藏
页码：2095 / 2115
页数：21
相关论文
共 50 条
  • [21] Nose-to-Brain Delivery of Biomimetic Nanoparticles for Glioblastoma Targeted Therapy
    Ferreira, Natalia Noronha
    Leite, Celisnolia Morais
    Moreno, Natalia Sanchez
    Miranda, Renata Rank
    Lins, Paula Maria Pincela
    Rodero, Camila Fernanda
    de Oliveira Junior, Edilson
    Lima, Eliana Martins
    Reis, Rui M.
    Zucolotto, Valtencir
    ACS APPLIED MATERIALS & INTERFACES, 2024, 17 (01) : 484 - 499
  • [22] Nose to brain delivery of selegiline loaded PLGA/lipid nanoparticles: Synthesis, characterisation and brain pharmacokinetics evaluation
    Raman, Subashini
    Khan, Arshad Ali
    Mahmood, Syed
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2022, 77
  • [23] Nose-to-brain delivery of BACE1 siRNA loaded in solid lipid nanoparticles for Alzheimer's therapy
    Rassu, Giovanna
    Soddu, Elena
    Posadino, Anna Maria
    Pintus, Gianfranco
    Sarmento, Bruno
    Giunchedi, Paolo
    Gavini, Elisabetta
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2017, 152 : 296 - 301
  • [24] Modulating chitosan-PLGA nanoparticle properties to design a co-delivery platform for glioblastoma therapy intended for nose-to-brain route
    Ferreira, Natalia N.
    Granja, Sara
    Boni, Fernanda, I
    Prezotti, Fabiola G.
    Ferreira, Leonardo M. B.
    Cury, Beatriz S. F.
    Reis, Rui M.
    Baltazar, Fatima
    Gremiao, Maria Palmira D.
    DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2020, 10 (06) : 1729 - 1747
  • [25] Nose-to-brain delivery of nano-engineered biomaterials for effective targeting to the brain
    Kashif, Mehboob Ur Rehman
    Sohail, Muhammad
    Mahmood, Arshad
    Shah, Syed Ahmed
    Abbasi, Mudassir
    Kousar, Mubeen
    INTERNATIONAL JOURNAL OF POLYMERIC MATERIALS AND POLYMERIC BIOMATERIALS, 2024,
  • [26] A Dry Powder Platform for Nose-to-Brain Delivery of Dexamethasone: Formulation Development and Nasal Deposition Studies
    Nizic Nodilo, Laura
    Ugrina, Ivo
    Spoljaric, Drago
    Amidzic Klaric, Daniela
    Jakobusic Brala, Cvijeta
    Perkusic, Mirna
    Pepic, Ivan
    Lovric, Jasmina
    Sarson, Vesna
    Safundzic Kucuk, Masa
    Zadravec, Dijana
    Kalogjera, Livije
    Hafner, Anita
    PHARMACEUTICS, 2021, 13 (06)
  • [27] Nanonized carbamazepine for nose-to-brain delivery: pharmaceutical formulation development
    Bonaccorso, Angela
    Gigliobianco, Maria Rosa
    Lombardo, Rosamaria
    Pellitteri, Rosalia
    Di Martino, Piera
    Mancuso, Antonia
    Musumeci, Teresa
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2023, 28 (02) : 248 - 263
  • [28] Liposomal Formulations for Nose-to-Brain Delivery: Recent Advances and Future Perspectives
    Hong, Soon-Seok
    Oh, Kyung Taek
    Choi, Han-Gon
    Lim, Soo-Jeong
    PHARMACEUTICS, 2019, 11 (10)
  • [29] Nose-to-Brain Delivery of Dexamethasone: Biodistribution Studies in Mice
    Nicolas Perez-Osorio, Ivan
    Espinosa, Alejandro
    Giraldo Velazquez, Manuel
    Padilla, Patricia
    Barcena, Brandon
    Fragoso, Gladis
    Jung-Cook, Helgi
    Besedovsky, Hugo
    Meneses, Gabriela
    Sciutto Conde, Edda Lydia
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2021, 378 (03) : 244 - 250
  • [30] A technological comparison of freeze-dried poly-ε-caprolactone (PCL) and poly (lactic-co-glycolic acid) (PLGA) nanoparticles loaded with clozapine for nose-to-brain delivery
    Lombardo, Rosamaria
    Ruponen, Marika
    Rautio, Jarkko
    Lampinen, Riikka
    Kanninen, Katja M.
    Koivisto, Anne M.
    Penttila, Elina
    Lopponen, Heikki
    Demartis, Sara
    Giunchedi, Paolo
    Rassu, Giovanna
    Fragala, Maria Elena
    Pignatello, Rosario
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2024, 93
12345